Extracellular matrix molecules in chronic obstructive sialadenitis: an immunocytochemical and Western blot investigation.
The exact pathomechanism of inflammation progress and fibrosis in chronic sialadenitis is unknown. Connective tissue growth factor (CTGF), matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) have been implicated in the pathogenesis of various fibrotic conditions. These factors are thought to be essential in the regulation of extracellular matrix turnover and the development of tissue fibrosis. In the present study, the expression of CTGF, MMP-2, -3, -9, -13 and TIMP-3 was examined in chronic obstructive sialadenitis. Tissue samples of 13 patients with chronic sialadenitis of the submandibular gland associated with sialolithiasis and 4 normal tissue samples of the submandibular gland were analyzed immunohistochemically and by Western blot analysis. An intense CTGF immunoreactivity was observed in the ductal system of inflamed salivary glands, whereas in normal glands no reactivity or a very low CTGF immunoreactivity was present. Immunohistochemical studies revealed a low to strong reactivity of MMP-2, -3, -9, -13, and TIMP-3 in the ductal system, in acinar cells and in lymphomonocytic infiltrates in normal and inflamed tissues. The expression of MMP-2, -3, -9, -13, and TIMP-3 was confirmed by Western blotting in all cases. Over-expression of CTGF in chronic obstructive sialadenitis suggests that this factor may play a role in glandular fibrosis. However, the physiological role of MMP-2, -3, -9, -13, and TIMP-3 in normal glands, as well as their possible role in inflammation progress and fibrosis in chronic obstructive sialadenitis, remains to be elucidated.
Teymoortash
Afshin
A
Department of Otolaryngology, Head and Neck Surgery, Philipps University, Marburg, Germany. teymoort@med.uni-marburg.de
Mandic
Robert
R
Schrader
Carsten
C
Werner
Jochen Alfred
JA
D015153:Blotting, Western; D016022:Case-Control Studies; D002908:Chronic Disease; D055513:Connective Tissue Growth Factor; D016326:Extracellular Matrix Proteins / Q000096:biosynthesis*; D005260:Female; D005355:Fibrosis; D006801:Humans; D017874:Immediate-Early Proteins / Q000096:biosynthesis; D007150:Immunohistochemistry; D036341:Intercellular Signaling Peptides and Proteins / Q000096:biosynthesis; D008297:Male; D020782:Matrix Metalloproteinases / Q000096:biosynthesis; D008875:Middle Aged; D015494:Salivary Gland Calculi / Q000201:enzymology* / Q000473:pathology; D012793:Sialadenitis / Q000201:enzymology* / Q000473:pathology; D013364:Submandibular Gland Diseases / Q000201:enzymology* / Q000473:pathology; D019717:Tissue Inhibitor of Metalloproteinase-3 / Q000096:biosynthesis
C526317:CCN2 protein, human; D016326:Extracellular Matrix Proteins; D017874:Immediate-Early Proteins; D036341:Intercellular Signaling Peptides and Proteins; D019717:Tissue Inhibitor of Metalloproteinase-3; D055513:Connective Tissue Growth Factor; D020782:Matrix Metalloproteinases